Clinical trial
Study to Evaluate MEDI-534 in Healthy Adults
NCT00111878 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00111878 |
|---|---|
| Title | Study to Evaluate MEDI-534 in Healthy Adults |
| Official title | Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Respiratory Syncytial Virus Infections, Parainfluenza Infections |
| Intervention type | Drug |
| Interventions | MEDI-534 |
| Enrollment | 120 |
| Start date | Apr 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | May 27, 2005 |
| Last update posted | Jul 3, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: